Skip to content
Save up to 80% on your medications — Fast delivery
Synalar
Guaranteed quality
Discreet shipping
Returns

Synalar

5 customer reviews
Delivery: 4–7 days
Secure payment methods
24/7 Support
Active ingredient: Fluocinolone acetonide
Package Per unit Price
SSL Secure
Certified pharmacy
Money-back guarantee

Synalar is a topical corticosteroid ointment containing fluocinolone acetonide. It is for people with steroid-responsive eczema, psoriasis, or dermatitis flare-ups. It works locally to reduce skin inflammation and itching.

What is it?

Synalar is a topical medication whose main active ingredient is Fluocinolone Acetonide (also referred to as Fluocinolone in some clinical resources). It belongs to the corticosteroid class, sometimes called topical steroids, used on the skin to control inflammatory reactions.

It is used in short courses during flare-ups.
It is not a moisturiser.
It is not an antibiotic.

Composition

Active substance: fluocinolone acetonide. Dosage forms commonly include Synalar ointment/cream for topical skin use, and Synalar solution for scalp areas, supplied in tubes (ointments/creams). Excipients vary by formulation and manufacturer batch.

How to use?

Apply a thin layer of Synalar to the affected area once or twice a day, then rub in gently until it disappears into the skin. Use it only on the areas that need treatment, and stop once the flare is controlled unless your prescriber has given a tapering plan.

A practical way to avoid overuse is to treat it like “spot therapy,” not a body lotion. Keep applications consistent during the flare, then step down when calm returns.

A simple application routine

  1. Wash hands and dry them well.
  2. Apply a thin film to the affected skin only.
  3. Rub in gently; don’t scrub.
  4. Wash hands again (unless hands are the treated area).

If you miss an application, just apply the next one at the usual time. Doubling up tends to increase irritation and steroid side effects without faster clearing.

How does it work?

  • Route: topical (apply to skin).
  • Dose/strength: Synalar ointment/cream 0.025% (0.25 mg/g).
  • How much: apply a thin film to affected area.
  • Frequency: 2–4 times/day.
  • Timing: apply at evenly spaced times during the day; no relation to meals.
  • Duration: use for the shortest effective course, typically up to 1–2 weeks unless a prescriber directs otherwise.
  • Avoid: eyes, mouth, broken skin; do not cover with occlusive dressings unless prescribed.

Indications

Synalar is used for the relief of inflammatory and pruritic (itchy) manifestations of corticosteroid-responsive dermatoses. In practical terms, doctors use it for:

  • Eczema (atopic dermatitis flare-ups)
  • Dermatitis (including allergic or irritant dermatitis, when steroid-responsive)
  • Psoriasis (selected areas and short courses, depending on severity and site)

It works best when the main issue is inflammation. If the main issue is infection, Synalar alone is usually the wrong tool, because it does not treat bacteria, fungi, or viruses [2].

Comparison

Cream and ointment versions of Synalar are used for the same general purpose, but they behave differently on the skin.

  • Synalar Cream is lighter and tends to suit moist or weeping areas, and places where a greasy feel is not tolerated well.
  • Synalar Ointment is greasier and more occlusive, which often makes it a better fit for dry, scaly, or lichenified (thickened from scratching) skin.

A common real-world pattern is that people prefer cream in the daytime and ointment at night because ointment can transfer to clothing. Some clinicians also use ointment on hands and feet where skin is thick, and reserve cream for less dry areas.

Contraindications

  • Hypersensitivity/allergy to fluocinolone acetonide, Fluocinolone, or other corticosteroids
  • Untreated bacterial, fungal, or viral skin infection at the application site
  • Rosacea or perioral dermatitis on the face

Not recommended for

Do not use Synalar unless a clinician has made a specific plan if you have a known steroid allergy, if the skin area looks infected (for example yellow crusting, pus, spreading redness, or a new painful rash), or if the rash is rosacea/perioral dermatitis on the face where steroids often worsen it. Extra caution is needed in pregnancy, breastfeeding, and for children because more of the steroid can be absorbed through the skin, especially with larger areas or longer use. Seek urgent assessment rather than masking symptoms with a steroid if you have a widespread rash with fever or rapidly spreading skin pain.

Side effects

Most people tolerate Synalar well when used as directed, but topical steroids can still cause local side effects. The more you apply, the longer you use it, and the more delicate the skin site, the higher the risk.

More common local effects

  • Burning, stinging, or irritation soon after applying
  • Dryness or peeling
  • Acne-like spots (steroid acne), often on the face or trunk
  • Folliculitis (inflamed hair follicles)

With longer use or use on sensitive sites

  • Skin thinning (atrophy)
  • Visible small blood vessels (telangiectasia)
  • Stretch marks (striae), often in folds
  • Changes in skin colour

Serious effects from absorption through the skin are uncommon with short, local use, yet they become more plausible when steroids are used on large areas, under occlusion, or for long durations. This is one reason regulators and clinical guidance emphasise short courses and careful site choice [3].

Common mistakes

These are the patterns that most often lead to poor results or avoidable side effects.

  • Using Synalar as a full-body moisturiser instead of spot treatment on inflamed patches.
  • Applying too thick a layer, expecting faster clearing.
  • Stopping after one or two days because the redness faded, then rebounding because the inflammation was not fully settled.
  • Using it on a rash that is actually fungal (ring-like edge, persistent itch, worsening with steroid), where steroids can make it spread.
  • Applying it right before heavy sweating or gym sessions, then wiping it away repeatedly, which leads to erratic dosing.

A small detail many people miss: if you are using other topical products, give Synalar a little space. Applying multiple layers back-to-back can dilute the steroid and increases the temptation to “reapply,” which is how overuse starts.

Doctor opinions

Clinicians often frame Synalar as a “flare controller,” not a daily maintenance product. Used at the right moment, it can prevent a mild flare from escalating into widespread scratching, broken skin, and secondary infection risk.

Dermatology prescribing patterns also reflect body site. Doctors tend to keep topical steroids lower and shorter on thin skin (face, eyelids, genital area), and they are more comfortable using ointments on thicker plaques where dryness and scaling dominate.

A pragmatic clinical observation is that patients who pair Synalar with consistent emollients often need fewer steroid days across the month. The steroid calms the immune reaction; the moisturiser restores the barrier, which reduces the triggers that restart the cycle.

Frequently asked questions

Many people feel less itch within the first day, while visible redness can take a few days to settle, depending on how inflamed the skin is. Topical corticosteroids like fluocinolone acetonide work by reducing inflammatory mediators in the skin rather than acting like a painkiller, so the “look” can lag behind the “feel.” In 2026, MOHAP patient-education materials for topical steroids still emphasise short, targeted courses for flare control rather than continuous use [5]. This lines up with what clinicians see in practice: fast symptom relief, then gradual clearing.

Doctors usually limit steroid strength, area, and duration on the face, eyelids, groin, and armpits because these sites absorb more and thin faster. Synalar may be used on these areas only when a clinician has weighed benefit vs risk and given a short plan. If you need repeated courses on facial skin, it often signals rosacea, perioral dermatitis, or contact allergy, where steroid use can backfire. EMA safety communications on topical corticosteroids continue to focus on preventing avoidable local side effects by careful site selection.

Using extra once is unlikely to cause harm, but repeated overuse raises the chance of skin thinning, stretch marks, and systemic absorption. Wipe off excess gently if there is a visible layer sitting on the skin, then return to the planned schedule. If you applied it under a tight dressing or over a large area for several days, seek medical advice because absorption can increase significantly under occlusion. WHO guidance on rational use of medicines also highlights dose minimisation for steroids when possible.

Avoid eyes, eyelids (unless specifically directed), open wounds, and infected skin. Be cautious on the face and genitals due to higher absorption and faster thinning. If you have psoriasis, steroid use on large areas without a structured plan can lead to rebound flares, so clinicians often combine steroids with other strategies. EMA pharmacovigilance summaries for topical steroids keep skin atrophy and site-specific risk as core counselling points.

Covering the treated area with a bandage or dressing can increase steroid penetration, which may increase effect but also increases side effects and systemic absorption risk. For that reason, occlusion is used only when a clinician recommends it, for a specific duration and site. In routine home use, leaving the area uncovered after rubbing in a thin layer is safer and more predictable. This aligns with standard topical corticosteroid safety recommendations referenced in clinical drug monographs reviewed by regulators.

Front view Front view
Side view Side view
Back view Back view

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.

Synalar — Comparison with alternatives

Synalar Forms and Strengths

Synalar exists in different topical dosage forms in general clinical use, including cream, ointment, and gel, with formulations designed to match different skin types and body areas.

On this page, Synalar is supplied as an ointment in tubes. Ointments are oil-based and more occlusive, which can be a real advantage for very dry, thickened, or scaly patches because they reduce water loss from the skin and help the steroid stay in contact longer.

Reviews and Experiences

M
Mariam, 34
Dubai
7 days
Verified
My hand eczema calmed down by day three and the cracks stopped splitting. The ointment felt greasy, so I used it after dinner and wore cotton gloves for an hour.
18/10/2025
O
Omar, 41
Abu Dhabi
10 days
Verified
It took the itch away fast, but I overdid it at first and my skin got shiny and thin-looking around the patch. When I switched to a thin layer, it still worked without that tight feeling.
07/01/2026
S
Sara, 29
Sharjah
5 days
Verified
Good for a flare on my neck, but it stung on the first two applications because the skin was raw. Putting moisturiser earlier in the day helped.
22/03/2026
H
Hassan, 46
Al Ain
3 weeks
Verified
It controlled redness, but the rash kept coming back because I was using it without fixing the trigger from a new scented soap. Once I stopped the soap, I needed much less Synalar.
11/12/2025
L
Leila, 52
Manchester
6 days
Verified
It helped my eczema patch, but I wished I had been told more clearly to stop once the skin settled. I kept using it a few extra days and the area felt a little too dry.
05/02/2026

Sources

  1. Cleveland Clinic (2026). Fluocinolone topical: Uses and patient guidance.
  2. European Medicines Agency (EMA) (2026). Topical corticosteroids: risk minimisation and pharmacovigilance overview.
  3. World Health Organization (WHO) (2025). WHO model formulary: corticosteroids for dermatological use.
  4. World Health Organization (WHO) (2026). Rational use of medicines: principles for minimising harm with corticosteroids.
  5. MOHAP (Ministry of Health and Prevention, UAE) (2026). Patient education: topical steroid use for eczema and dermatitis.